A Trial of a New Magnetic Breast Marking Clip
Phase 1 Study of Magnetic Breast Marking Clip System MagneMark
2 other identifiers
interventional
3
1 country
1
Brief Summary
This small pilot will allow surgeons to perform wireless breast lumpectomies using a new magnetic technology. This is a continuation of a previous project testing the technology, and the breast surgeons comfort level using this new technology. The aim of this project is to develop a new technique for surgical excision of lesions either through surgical biopsy or lumpectomy. The current standard of care involves placing a needle then slender wire through the lesion under image guidance by a radiologist. The surgeon then removes the lesion using the wire as a guide. This new technique would place a magnet through the lesion under image guidance by a radiologist. The surgeon would then use the MagneProbe in the operating room to locate the magnet and remove the lesion. This new technique would eliminate the use of a wire that protrudes from a patient's breast. This wire is usually placed on the day of surgery, prior to the procedure. The goal of this new technique is to eliminate wire placement and increase patient comfort throughout the day of her surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2015
CompletedStudy Start
First participant enrolled
March 1, 2015
CompletedFirst Posted
Study publicly available on registry
March 4, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedDecember 14, 2023
December 1, 2023
3.4 years
February 19, 2015
December 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Completeness of Excision
Investigators anticipate that cases using this localization and excision technique will be successful at minimum 96% of the time. The rate at which excision is successful using traditional methods. This outcome will be assessed and presented at the completion of the trial at the end of one year
1 year
Secondary Outcomes (1)
Time for excision
1 year
Study Arms (1)
Investigational Device
EXPERIMENTALAll patients will undergo breast localization and excision of a lesion using the MagneMark system. The radiologist will insert the MagneMarker clip into the area of concern using the MagneJector device. The surgeon will then locate the MagneMaker clip using the MagneProbe. The clip and breast tissue of concern will then be removed.
Interventions
The MagneMarker system includes a magnetic clip the MagneMarker, a clip placement device the MagneJector, and a magnetic field detecting probe the MagneProbe. The MagneMarker and MagneJector are used by a radiologist during a breast localization procedure. The MagneProbe is used by a surgeon to locate the MagneMarker during breast excision.
Eligibility Criteria
You may qualify if:
- i) Female ii) Ages 19-100 iii) Have a single breast lesion that has been previously biopsied and iv) Is discretely identified by:
- A metallic biopsy site marker or
- Ultrasound or
- Mammography and v) Is scheduled for preoperative needle localization with a single wire and vi) Is English speaking vii) Is capable of making medical decisions, not cognitively impaired viii) Is being localized by a study radiologist or can be rescheduled to be localized by a study radiologist
You may not qualify if:
- i) Cognitively impaired adults ii) Non- English speakers ii) Men
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Antonios Likourezoslead
- MagneMark LLCcollaborator
Study Sites (1)
Maimonides Medical Center
Brooklyn, New York, 11220, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Donna Marie Manasseh, MD
Chief, Division of Breast Surgery Director, Maimonides Breast Cancer Program Maimonides Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Research Administration Director
Study Record Dates
First Submitted
February 19, 2015
First Posted
March 4, 2015
Study Start
March 1, 2015
Primary Completion
August 1, 2018
Study Completion
August 1, 2018
Last Updated
December 14, 2023
Record last verified: 2023-12